Stepan Company

Valuation Analysis

About the Company

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients; emulsifiers for spreading agricultural products; and industrial applications comprising latex systems,

Stepan Company Stock at a Glance

Stepan Company (SCL) is currently trading at $54.48 with a market capitalization of $1.2B. The 52-week range spans from $41.82 to $68.00; the current price is 19.9% below the yearly high. Year-over-year revenue growth stands at +1.9%.

💰 Dividend

Stepan Company pays an annual dividend of $1.58 per share, representing a yield of 2.9%. The payout ratio stands at 75.61%.

📊 Analyst Rating

1 analysts rate Stepan Company (SCL) on consensus: None. The average price target is $75.00, implying +37.67% from the current price. Analyst price targets range from $75.00 to $75.00.

Stepan Company: The Investment Case in Detail

Stepan Company (SCL) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

Revenue growth has slowed to just 1.9%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

Valuation in Context

The EV/EBITDA multiple of 9.74x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

What to Watch Next

• The analyst consensus price target implies 37.67% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Stepan Company?

Compare top-rated brokers — low fees, trusted providers, fully regulated.